Amgen

Amgen CFO talks Q2 earnings, obesity drug, and growth

Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better

Amgen: How Biotechnology is Transforming Medicine

Cramer’s Mad Dash: Amgen

Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz

How Amgen is using Generative Biology and AI

Cell Culture and Expansion - Biotech Manufacturing at Amgen

Welcome to Amgen Ohio

ANÁLISIS TÉCNICO DE ACCIONES: AIRBNB, DISNEY, RIVIAN, DEVON, SHOPIFY, CVS, SONY y AMGEN

Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen

Amgen’s Research & Development (R&D) Vision

The Next Generation of Biomanufacturing at Amgen

Amgen’s North Carolina Groundbreaking

Amgen has great science, but they don't seem to make it across the finish line, says Jim Cramer

The Amgen Difference - Our People, Our Values

Biologics Manufacturing : Video 1 - Clean Environment

Cramer’s Stop Trading: Amgen

Amgen Shares Soar on Obesity Drug Progress

Amgen Thousand Oaks Virtual Tour

What is the Amgen Foundation?

Amgen's obesity drug plans, outlook for 2024

Welche Aktie hat es ins Depot geschafft ? | Amgen Aktie vs Abbvie Aktie

Amgen (AMGN) - Quick Stock Analysis

Is Amgen Stock a Buy Now!? | AMGN Stock Analysis